Why now? We just got results and are getting more results shortly. I would guess we have multiple submissions to multiple regulatory bodies. Maybe Fadiran wrapped it all in a nice package with supporting OLE and data across multiple CNS diseases that can’t be ignored. Who knows, but something is happening.
IMO, a basket trial of a type w/scope to validate our CNS Cellular Homeostasis claim MOA is about ready to be proposed. Multiple indications being addressed via individual trials but each having the same MOA. Mind-blowing but that is most likely what is in the works. Not a sci fi movie, all based on Precision Medicine concepts leading to basic restoration and regeneration. All will get some, some will get all.